Effect of CAFfeine on Cognition in Alzheimer's Disease
Conditions
Alzheimer Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU Amiens, Amiens, France
Contact: Study coordinator (Olivier GODEFROY, MD)CH Arras, Arras, France
Contact: Study coordinator (Patrick LE COZ, MD)CH Beauvais, Beauvais, France
Contact: Study coordinator (Xavier CNOCKAERT, MD)CH Béthune, Béthune, France
Contact: Study coordinator (Isabelle LAVENU, MD)CHU Caen, Caen, France
Contact: Study coordinator (Olivier MARTINAUD, MD)CH Calais, Calais, France
Contact: Study coordinator (Olivier DEREEPER, MD)CH Dunkerque, Dunkirk, France
Contact: Study coordinator (Abdelghani EL AZOUZI, MD)CH Le Quesnoy, Le Quesnoy, France
Contact: Study coordinator (Denis LEFEBVRE, MD)CH Lens, Lens, France
Contact: Study coordinator (Olivier SENECHAL, MD)Hôpital Roger Salengro, Lille, France
Contact: Principal Investigator (Thibaut Lebouvier, MD)CHU Lille consultation mémoire Les Bâteliers, Lille, France
Contact: Study coordinator (Dominique HUVENT, MD)CH Roubaix, Roubaix, France
Contact: Study coordinator (Pierre FORZY, MD)CHU Rouen, Rouen, France
Contact: Study coordinator (David WALLON, MD)CH Saint Quentin, Saint-Quentin, France
Contact: Study coordinator (Jadwiga ATTIER-ZMUDKA, MD)CH Seclin, Seclin, France
Contact: Study coordinator (Véronique BERRIOT, MD)CH Tourcoing, Tourcoing, France
Contact: Study coordinator (Karim GALLOUJ, MD)CH Valenciennes, Valenciennes, France
Contact: Study coordinator (Anne DESPREZ, MD)
Study leads
thibaud LEBOUVIER, MD,PhD
Principal Investigator
University Hospital, Lille